Also, 70% of T-ALL have lost the P16/INK4A, P19/ARF tumor suppressors leading to unrestrained stimulation of cyclin-CDK complexes and cell cycle progression on one arm and inactivation of the p53 tumor suppressor response on the other. Here, CDKN2A is linked to acute lymphoblastic leukemia.